| 完全弗氏佐剂抑制NOD鼠胰岛β细胞凋亡及其机制 |
| |
| 引用本文： | 朱琳,周智广,杨文,杨竹林,张松. 完全弗氏佐剂抑制NOD鼠胰岛β细胞凋亡及其机制[J]. 中南大学学报(医学版), 2006, 31(6): 834-837 |
| |
| 作者姓名： | 朱琳 周智广 杨文 杨竹林 张松 |
| |
| 作者单位： | 中南大学湘雅二医院代谢内分泌研究所,长沙,410011;中南大学湘雅二医院糖尿病中心,长沙,410011;中南大学湘雅二医院肝胆疾病研究室,长沙,410011 |
| |
| 基金项目： | 国家自然科学基金;湖南省中青年基金 |
| |
| 摘 要： | ![]()
目的:探讨完全弗氏佐剂( complete Freund’s adjuvant, CFA)对非肥胖糖尿病( nonobese dia-betic, NOD)鼠胰岛β细胞凋亡及凋亡相关基因Fas,FasL和Bcl-x表达的影响。方法:将4周龄NOD雌鼠随机分为CFA组(n=5)和生理盐水( NS)对照组(n=5 ) ,给CFA组鼠后脚板注射50μLCFA,对照者鼠后脚板注射等量NS。监测血糖,若血糖连续2 d≥11.1 mmol /L即诊断为糖尿病。当NOD鼠发生糖尿病或至30周龄时,处死动物,取胰腺组织制成薄切片,HE染色观察胰岛炎,采用末端脱氧核苷酸转移酶介导的脱氧尿苷三磷酸缺口末端标记( TUNEL)及ABC免疫组织化学双标记染色观察并计数凋亡的胰岛β细胞,ABC免疫组织化学法染色观察并记数Fas,FasL和Bcl-x表达阳性细胞。结果:至NOD鼠30周龄时,CFA处理组鼠无1只发生糖尿病,对照组鼠有3只发生糖尿病;CFA处理组的胰岛炎积分低于NS对照组(1.820±0.962 vs. 3.020±1.040,P<0.05 ) ;CFA处理组胰岛β细胞凋亡率、Fas阳性细胞率、FasL阳性细胞率均低于NS对照组[ (10.2±2.8) % vs. (15.9±6.5) %,(54.9±14.5)% vs.(75.7±12.9) %,(20.3±10.4) % vs. (27.9±12.0) %,P<0.05] ,Bcl-x阳性细胞率高于NS对照组[ (74.9±10.7) % vs. (66.0±18.3) %,P<0.05]。结论:CFA能够减轻NOD鼠胰岛β细胞凋亡,其机制与减少促凋亡基因Fas和FasL表达及增加抑制凋亡基因Bcl-x表达有关。
|
| 关 键 词： | 完全弗氏佐剂 NOD鼠 Fas抗原 Fas配体 Bcl-x 凋亡 胰岛炎 糖尿病 |
| 文章编号： | 1672-7347（2006）06-0834-04 |
| 收稿时间： | 2006-06-27 |
| 修稿时间： | 2006-06-27 |
|
| |
| ZHU Lin,ZHOU Zhi-guang,YANG Wen,YANG Zhu-lin,ZHANG Song.
|
| |
| Authors: | ZHU Lin ZHOU Zhi-guang YANG Wen YANG Zhu-lin ZHANG Song |
| |
| Affiliation: | Diabetes Center, Second Xiangya Hospital, Central South University, Changsha 410011, China. |
| |
| Abstract: | ![]()
OBJECTIVE: To investigate the effect of complete Freund's adjuvant (CFA) on islet beta cell apoptosis in preventing diabetes in non-obese diabetic (NOD) mice, and the influence on apoptotic related-gene expression. METHODS: Four-week-old female NOD mice were randomly divided into Group CFA (n=5) and Group saline (NS) control (n=5). Mice in Group CFA were injected in the hind footpad with 50 microL CFA and mice in Group NS with 50 microL NS. Blood sugar was monitored and diabetes was diagnosed if blood sugar was higher than 11.1 mmol/L for 2 continuous days in the NOD mice. The mice were sacrificed when diagnosed as diabetes or at 30 weeks of age. Pancreatic sections were made for: evaluation of insulitis severity with HE staining; counting of apoptotic beta cells with the terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling (TUNEL) method, and ABC immunohistochemical double labeling; counting of Fas, FasL and Bcl-x positive cells respectively with ABC immunohistochemical method. RESULTS: By 30 weeks of age, none of the 5 CFA-treated mice, compared with 3 of the 5 control mice, had developed diabetes. The insulitis score was lower (1.820+/-0.962 vs. 3.020+/-1.040, P<0.05), the rates of apoptotic beta cells, Fas positive cells and FasL positive cells were lower [(10.2+/-2.8)% vs. (15.9+/-6.5)%, (54.9+/-14.5)% vs. (75.7+/-12.9)%, (20.3+/-10.4)% vs. (27.9+/-12.0)%, P<0.05), and the Bcl-x positive cell rate was higher [(74.9+/-10.7)% vs. (66.0+/-18.3)%, P<0.05] in the CFA-treated group than those in the NS-treated group respectively. CONCLUSION: CFA may inhibit beta cell apoptosis in NOD mice by regulating Fas, FasL and Bcl-x expression on cells within islets. |
| |
| Keywords: | Bcl-x |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《中南大学学报(医学版)》浏览原始摘要信息 |
|
点击此处可从《中南大学学报(医学版)》下载全文 |
|
